请输入关键字
请输入关键字
产品管线
开发满足患者需求的创新型抗体药物
百奥赛图致力于开发出满足患者需求的创新型抗体药物,聚焦肿瘤、自身免疫、代谢及抗感染等多个疾病领域,充分利用独特的创新药物开发优势,现已拥有包含单克隆抗体、双特异性抗体、ADC药物等在内的十多个研发管线。在强大的临床开发团队和丰富的临床资源加持下,全速推进具有巨大潜力的产品管线,加速药物临床试验进程。
Therapeutic Area
Products
Target
Partner
Molecular Format
Indication
Status
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
Oncology
YH003
CD40
Monoclonal Antibody
Solid Tumor
查看更多
YH001
CTLA-4
Monoclonal Antibody
Solid Tumor
查看更多
YH002
OX40
Monoclonal Antibody
Solid Tumor
查看更多
YH004
4-1BB
Monoclonal antibody
查看更多
YH008
PD-1/CD40
Bi-specific antibody
查看更多
YH005
Not Disclosed
Remegen
ADC
YH010
Not Disclosed
Bi-specific antibody
YH006
Not Disclosed
Bi-specific antibody
Infectious Diseases
YH007
SARS-CoV-2
mAb cocktail
查看更多
YH009
RSV
Monoclonal antibody
查看更多
Pet Oncology
MP001
dog PD-1
Monoclonal antibody
MP002
dog CTLA-4
Monoclonal antibody
Oncology
YH003
查看更多
Target:
CD40
Partner:
Molecular Format:
Monoclonal Antibody
Indication:
Solid Tumor
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
YH001
查看更多
Target:
CTLA-4
Partner:
Molecular Format:
Monoclonal Antibody
Indication:
Solid Tumor
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
YH002
查看更多
Target:
OX40
Partner:
Molecular Format:
Monoclonal Antibody
Indication:
Solid Tumor
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
YH004
查看更多
Target:
4-1BB
Partner:
Molecular Format:
Monoclonal antibody
Indication:
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
YH008
查看更多
Target:
PD-1/CD40
Partner:
Molecular Format:
Bi-specific antibody
Indication:
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
YH005
查看更多
Target:
Not Disclosed
Partner:
Remegen
Molecular Format:
ADC
Indication:
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
YH010
查看更多
Target:
Not Disclosed
Partner:
Molecular Format:
Bi-specific antibody
Indication:
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
YH006
查看更多
Target:
Not Disclosed
Partner:
Molecular Format:
Bi-specific antibody
Indication:
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
Infectious Diseases
YH007
查看更多
Target:
SARS-CoV-2
Partner:
Molecular Format:
mAb cocktail
Indication:
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
YH009
查看更多
Target:
RSV
Partner:
Molecular Format:
Monoclonal antibody
Indication:
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
Pet Oncology
MP001
查看更多
Target:
dog PD-1
Partner:
Molecular Format:
Monoclonal antibody
Indication:
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
MP002
查看更多
Target:
dog CTLA-4
Partner:
Molecular Format:
Monoclonal antibody
Indication:
Discovery
Pre-clinical
IND
Phase l
Phase ll
Phase lll
BLA
百奥赛图已与全球多家药企达成全人抗体小鼠平台授权,抗体药物开发战略合作,点下方按钮了解合作模式。管线项目相关合作请联系:bd@eucure.com
合作模式